BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kong DR, Wang JG, Sun B, Wang MQ, Chen C, Yu FF, Xu JM. β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis. World J Gastroenterol 2015; 21(23): 7191-7196 [PMID: 26109805 DOI: 10.3748/wjg.v21.i23.7191]
URL: https://www.wjgnet.com/1007-9327/full/v21/i23/7191.htm
Number Citing Articles
1
E. L. Krasavtsev, A. V. Sennikova. ADRENERGIC AGENTS IN CORRECTION OF PORTAL HYPERTENSION IN CIRRHOSIS OF THE LIVERHepatology and Gastroenterology 2020; 4(1): 12 doi: 10.25298/2616-5546-2020-4-1-12-14
2
Pramod Kumar, Sunil Taneja, Virendra Singh. Beta‐blockers in patients with advanced liver disease: Has the dust settled?Liver Transplantation 2017; 23(10): 1351 doi: 10.1002/lt.24831
3
HaidarA N. Abood. Impact of 27gln\glu polymorphisms of β2-adrenergic receptor gene on pulmonary function in asthmatic children treated with nebulized salbutamolBiomedical and Biotechnology Research Journal (BBRJ) 2021; 5(4): 435 doi: 10.4103/bbrj.bbrj_67_21
4
Sarah Shalaby, Luisa Ronzoni, Virginia Hernandez‐Gea, Luca Valenti. The genetics of portal hypertension: Recent developments and the road aheadLiver International 2023; 43(12): 2592 doi: 10.1111/liv.15732
5
Tilman Sauerbruch, Martin Hennenberg, Jonel Trebicka, Robert Schierwagen. Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?Frontiers in Medicine 2023; 9 doi: 10.3389/fmed.2022.1100966
6
Seong Hee Kang, Moon Young Kim, Soon Koo Baik. Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizonHepatology International 2018; 12(S1): 112 doi: 10.1007/s12072-017-9806-1
7
AyatSahib Mohammed, HaidarAbdul Amir Najim Abood, AqeelMahdi Hussein. The effect of 16 Arg/Gly β2–adrenergic receptors gene polymorphism on pulmonary function in asthmatic children treated with nebulized salbutamolBiomedical and Biotechnology Research Journal (BBRJ) 2021; 5(2): 161 doi: 10.4103/bbrj.bbrj_36_21